InsiderTradesSIGMA

InsidersTradesSigma

Genmab A/S (GMAB.CO) — directors' dealings · insider filings · 140

← Companies ★ Sign in to follow

Genmab A/S: directors' dealings · Denmark · Finanstilsynet DK

DK:genmab-asDK0010272202DK·Finanstilsynet DKMcap 124.9Bn€

Explore the full management transaction log of Genmab A/S, a listed equity based in Denmark. Shares are listed on DK DK, under the authority of Finanstilsynet DK. Market capitalisation: €124.9bn. The latest transaction was disclosed on 1 April 2026 — Other. Among the most active insiders: Unknown. Every trade is accessible without an account.

140

Insider Decl.

0

Thresholds

€9m

16 ops.

Buy Volume

€33m

25 ops.

Sell Volume

Financial data

Income statement

Revenue3.72 Bn€

Gross profit3.48 Bn€94% margin

Net income963.0 M€25.9% margin

Balance sheet & cash

Market cap124.86 Bn€

Total debt5.43 Bn€

Free Cash Flow1.13 Bn€

Last declaration on 1 April 2026

All Executives140 Thresholds Prospectus Other

Declarations140 total

Executives●Other11DK FSA

U

DKK 2m8,525 shares@ DKK 235.30660.0016% mcap100.0% of flow

ShareOutside the market

DK:1430992·1 Apr 2026

Executives●Other11DK FSA

U

DKK 16 shares@ DKK 0.24090.0000% mcap100.0% of flow

ShareOutside the market

DK:1423836·2 Mar 2026

Executives●Other3DK FSA

U

0567 shares0

ShareOutside the market

DK:1423824·2 Mar 2026

Executives●Grant3DK FSA

U

033,293 shares0

ShareOutside the market

DK:1423440·27 Feb 2026

Executives●Sale5DK FSA

U

€217,775899 shares@ €242.24140.0002% mcap0.5% of flow

ShareXCSE

DK:1421715·19 Feb 2026

Executives●Other5DK FSA

U

€103,390378 shares@ €273.51890.0001% mcap0.2% of flow

ShareOutside a market place

DK:1403941·1 Dec 2025

Executives●Sale5DK FSA

U

€11,02442 shares@ €262.47960.0000% mcap0.0% of flow

ShareAQEU

DK:1401641·19 Nov 2025

Executives●Subscription6DK FSA

U

€3m23,266 shares@ €137.29050.0026% mcap7.3% of flow

ShareOutside the market

DK:1387733·9 Sept 2025

Executives●Sale5DK FSA

U

€4,77824 shares@ €199.09840.0000% mcap0.0% of flow

ShareXCSE

DK:1371150·17 Jun 2025

Executives●Other5DK FSA

U

0996 shares0

ShareOutside a market place

DK:1352989·1 Apr 2025

Executives●Grant5DK FSA

U

01,311 shares0

ShareOutside the market

DK:1348625·12 Mar 2025

Executives●Other5DK FSA

U

05,078 shares0

ShareOutside a market place

DK:1346934·3 Mar 2025

Executives●Grant5DK FSA

U

036,373 shares0

ShareOutside the market

DK:1346363·28 Feb 2025

Executives●Other5DK FSA

U

0454 shares0

ShareOutside a market place

DK:1331369·2 Dec 2024

Executives●Subscription6DK FSA

U

€3m24,461 shares@ €138.28280.0027% mcap7.7% of flow

ShareOutside the market

DK:1310577·13 Aug 2024

Executives●Sale5DK FSA

U

€1,5396 shares@ €256.57940.0000% mcap0.0% of flow

ShareAQEU

DK:1301181·10 Jun 2024

Executives●Grant5DK FSA

U

0837 shares0

ShareOutside the market

DK:1280998·13 Mar 2024

Executives●Purchase5DK FSA

U

€26,0917,000 shares@ €3.72730.0000% mcap0.1% of flow

ShareXNAS

DK:1279104·28 Feb 2024

Ideal exit: 24 Nov 2024 (T+270)

Executives●Other5DK FSA

U

05,630 shares0

ShareOutside a market place

DK:1278822·1 Mar 2024

Executives●Sale6DK FSA

U

€3m11,299 shares@ €260.60360.0024% mcap6.7% of flow

ShareAquis Exchange (AQEA, AQED, AQEU)

DK:1278470·28 Feb 2024

Executives●Subscription5DK FSA

U

€707,6425,147 shares@ €137.48630.0006% mcap1.6% of flow

ShareOutside the market

DK:1277786·27 Feb 2024

Executives●Grant5DK FSA

U

027,404 shares0

ShareOutside the market

DK:1277173·23 Feb 2024

Executives●Other5DK FSA

U

0335 shares0

ShareOutside a market place

DK:1267553·2 Jan 2024

Executives●Grant5DK FSA

U

0559 shares0

ShareOutside the market

DK:1260557·21 Nov 2023

Executives●Sale5DK FSA

U

€3,66010 shares@ €366.00090.0000% mcap0.0% of flow

ShareXCSE

DK:1231690·1 Jun 2023

25 of 140 declarations

About Genmab A/S

Genmab A/S is a Danish biopharmaceutical company focused on developing therapeutic antibodies for cancer treatment. It is listed on the Copenhagen Stock Exchange.